Stay updated on Pembrolizumab First-line in Advanced Merkel Cell Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab First-line in Advanced Merkel Cell Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab First-line in Advanced Merkel Cell Carcinoma Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision: v3.3.2 was added to the page footer, replacing the previous v3.3.1 revision; this is a cosmetic update with no impact on study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T17:08:52.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Publications note text updated to refer to 'results of the study' rather than 'study results', and the page revision label was updated to v3.3.1.
    Difference
    0.1%
    Check dated 2025-11-24T13:39:47.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    Removed the government funding lapse notice about NIH operations from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-17T06:28:31.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    A new Publications entry for Mortier et al., 2024 was added, and the Study Record Dates were updated to show the latest update date of 2025-05-28.
    Difference
    0.4%
    Check dated 2025-11-03T01:10:06.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Update to version v3.2.0 with a government operations notice; removal of a prior resource topic (Cutaneous neuroendocrine carcinoma) from the Genetic and Rare Diseases Information Center.
    Difference
    3%
    Check dated 2025-10-05T09:29:29.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Upgrade the revision from v3.0.2 to v3.1.0; core page content updated to reflect a new version.
    Difference
    0.1%
    Check dated 2025-09-28T03:09:57.000Z thumbnail image

Stay in the know with updates to Pembrolizumab First-line in Advanced Merkel Cell Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab First-line in Advanced Merkel Cell Carcinoma Clinical Trial page.